Anthem Biosciences had a robust launch on the stock exchanges today. On the NSE, the stock began trading at ₹723.05 each, ...

Anthem Biosciences debuted on the stock market on July 21, listing at ₹723.05 on NSE, a 26.85% premium over its IPO price.

Anthem Biosciences shares listed on the stock exchanges on Monday with a premium of about 27 percent over it's initial public ...

Anthem Biosciences share price on the BSE was trading at Rs. 730.70, up Rs. 7.60 or 1.05% from the listing price and a 28.19% ...

Anthem Biosciences Ltd ended its debut trading day with a premium of over 28%. Despite the high opening figures, the company ...

Contract research, development, and manufacturing organisation Anthem Biosciences shares recorded healthy returns on its ...

Ahead of its listing, Anthem Biosciences was commanding a strong grey market premium (GMP) of ₹179 in the unlisted market, ...

The IPO opened for subscription between July 14 and July 16, and was subscribed 67.42 times in total. Highest demand came ...

Anthem Biosciences, a leading contract research and manufacturing organization (CRDMO), made a strong debut on the Indian ...

Anthem Biosciences debuted at a 26.85 per cent premium on bourses, and soared to a high of ₹746.70 against listing price of ...

On the last 16 sessions grey market activities, the lowest GMP is Rs 0, while the highest GMP is Rs 171. So, if we go by the ...

Indian drugmaker Anthem Biosciences' ANTH.NS $395 million IPO was fully subscribed on the second day of bidding on Tuesday, ...